RNRMarketResearch.com

Consumption of Varicose Vein Treatment Products - Market Report by Surgical, Ablation and Treatment Mode

Press Release   •   May 16, 2016 03:37 EDT

The Varicose Vein Treatment Market in North America and Europe worth 289.7 Million USD by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021. The swollen, twisted veins that are visible under the skin are termed as varicose veins. Varicose veins can be formed anywhere in the body, but are often seen in the legs.

However, availability of a number of treatment devices such as laser ablation, radio frequency ablation, and sclerotherapy, among others across the North American and the European region is majorly contributing to the growth of the market.

Complete report on Varicose Vein Treatment Market spread across 149 pages, Profiling 6 Companies and supported with 67 Tables and 19 Figures is now available at http://www.rnrmarketresearch.com/varicose-vein-treatment-market-in-north-america-and-europe-by-treatment-mode-endovenous-ablation-sclerotherapy-stripping-products-laser-rf-ablation-venous-closure-surgical-forecasts-to-2021-market-report.html .

The major drivers for the varicose vein treatment market in North America and Europe include shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, huge burden of varicose vein cases in North America and Europe, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.

This report broadly segments the varicose vein treatment market into mode of treatment and products. The market, by products is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.

Varicose Vein Treatment Market in North America and Europe, by Mode of Treatment

  • Endovenous Ablation
  • Injection Sclerotherapy
  • Surgical Ligation/Stripping

Varicose Vein Treatment Market in North America and Europe, by Product

  • Ablation Devices
  • Radiofrequency Ablation
  • Laser Ablation
  • Venous Closure Products
  • Surgical Products

Interested in this report, Get sample copy of this research now

http://www.rnrmarketresearch.com/contacts/request-sample?rname=544012 .

This report covers the varicose vein treatment market across two major geographies, namely, North America and Europe. In this report, the North American market is further segmented into the U.S. and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the market in North America and Europe.

The major players in the varicose vein treatment market are Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.), among others

Click now for more discount on this research of “Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021” report @ http://www.rnrmarketresearch.com/contacts/discount?rname=544012 .

However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.

This report broadly segments the varicose vein treatment market into mode of treatment and products. On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The endovenous ablation segment is expected to command the major share of the market, by mode of treatment, in 2016.

On related note another research titled with therapeutic drug monitoring market is projected to reach USD 2.55 billion by 2020 from USD 1.78 billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020). In this report, the therapeutic drug monitoring market is broadly segmented by product, technology, class of drug, end user, and region is available at http://www.rnrmarketresearch.com/therapeutic-drug-monitoring-market-by-product-consumables-equipment-technology-immunoassays-proteomic-technologies-class-of-drug-antiepileptics-antibiotics-immunosuppressants-end-user-hospital-labs-pr-st-to-2020-market-report.html .

Explore more reports on Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics .

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
sales@rnrmarketresearch.com